Brought to you by:

Asia

Takeda
Favicon Fierce Pharma

Takeda targets $1.3B in savings with new efficiency drive

Takeda expects the new initiative will cost 150 billion Japanese yen ($940 million) in restructuring expenses during its 2026 fiscal year.
Angus Liu Mar 25, 2026 10:44am
NVS
Favicon Fierce Pharma

Novartis pledges nearly $480M to bolster China production, R&D

Mar 23, 2026 10:35am
AstraZeneca
Favicon Fierce Pharma

AZ to build cell therapy supply hub, R&D center in Shanghai

Mar 19, 2026 10:20am
Sanofi
Favicon Fierce Pharma

Sanofi inks $1.5B deal for Sino Biopharm's novel asset

Mar 4, 2026 3:00am
Astellas
Favicon Fierce Pharma

Astellas lifts forecast as Vyloy surge counters trial miss

Feb 5, 2026 11:00am
Akeso
Favicon Fierce Pharma

Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC

Oct 19, 2025 10:45am